Squalamine synthetic aminosterol small molecule regulatory update

MAGN received U.S. Patent No. 6,147,060 covering the use of its squalamine angiogenesis inhibitor to treat cancer. The product is in Phase II testing to treat non-small cell lung cancer (NSCLC) and ov...